Meni 8mg Tablet
Marketer
FDC Ltd
Salt Composition
Betahistine (8mg)
Overview Meni 8mg Tablet
Ménière's disease, an inner ear disorder causing vertigo, tinnitus, and hearing loss (potentially due to excess inner ear fluid), is treated and prevented with Meni 8mg Tablets. These tablets alleviate symptoms by decreasing fluid buildup. For optimal results, swallow Meni 8mg Tablets whole with water, consistently at the same time(s) daily, as directed by your physician. Treatment may extend for months; continue as prescribed, even with symptom improvement. Common side effects include nausea, headache, and dyspepsia; abdominal pain and bloating may also occur. Taking the medication with food may lessen gastrointestinal discomfort. Consult your doctor before use if you have a history of peptic ulcers, asthma, or hypertension/hypotension. Inform your doctor of all other medications you are currently using to ensure safe concurrent administration. Furthermore, discuss usage if you are pregnant, planning pregnancy, or breastfeeding.
Primary Ingredients of Meni 8mg Tablet
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Meni 8mg Tablet
Managing Meniere's disease
Major Benefits of Meni 8mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. The tablet should be swallowed whole; do not break, crush, or chew it. Meni 8mg Tablets can be administered with or without food, although consistent timing is recommended.
Common Side effects of Meni 8mg Tablet:
- Headache
- Indigestion
- Nausea
- Stomach pain
- Bloating
How to use Meni 8mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The 8mg Meni Tablet can be consumed with or without food, though consistent timing is recommended.
How Meni 8mg Tablet works:
Histamine analog Meni 8mg Tablet enhances inner ear circulation, thereby lessening excess fluid pressure. This fluid buildup can trigger vertigo, nausea, and dizziness—characteristic Ménière's disease symptoms—by transmitting aberrant signals to the brain. The tablet also attenuates these signals, mitigating Ménière's disease manifestations.
SAFETY ADVICE
AlcoholSAFE
Concurrent use of Meni 8mg Tablet and alcohol does not produce adverse reactions.
PregnancyCONSULT YOUR DOCTOR
The use of Meni 8mg Tablet during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Meni 8mg tablets while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Meni 8mg Tablets.
KidneySAFE IF PRESCRIBED
The use of Meni 8mg Tablet in individuals with kidney impairment appears to pose minimal risk. Current evidence indicates dose modification may not be necessary, but physician consultation is recommended.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the use of Meni 8mg Tablet in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Meni 8mg Tablet :
Omit any missed 8mg Meni Tablet dose and resume your usual regimen. Avoid taking a double dose.
Facts to Know About Meni 8mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Histamine-like compound |
| Developing Habits | No. |
| Treatment Category | Neuroscience Central Nervous System |
| Actions | Meniere's Disease and Histamine Analogs |



